Valproate hepatotoxicity: a review and report of two instances in adults.
Two patients with severe liver damage induced by sodium valproate are described. Both were adults. One had taken valproate for longer than one year before complications developed. The other, in whom the disorder was fatal, had a predominantly 'hepatic' pattern of liver damage with centrilobular necrosis and he also developed pancreatitis. The first patient, who recovered following cessation of valproate intake, manifested a predominantly cholestatic illness with portal tract inflammation. In addition he had a degree of reversible renal failure. Neither subject had microvesicular steatosis on liver biopsy. This report indicates that valproate hepatotoxicity is not always confined to children, that it may develop much later in the course of valproate therapy than has been previously recognized, that it is not necessarily fatal if valproate intake is ceased early enough, and that it may be associated with reversible renal insufficiency.
D000293:Adolescent; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D004569:Electroencephalography; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008107:Liver Diseases / Q000473:pathology; D008297:Male; D014635:Valproic Acid / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
D014635:Valproic Acid